CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review

Alzheimer’s disease (AD) is a chronic and irreversible neurodegenerative disorder characterized by cognitive deficiency and development of amyloid-β (Aβ) plaques and neurofibrillary tangles, comprising hyperphosphorylated tau. The number of patients with AD is alarmingly increasing worldwide; curren...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neurol Ther
Päätekijät: Barman, Nirmal Chandra, Khan, Niuz Morshed, Islam, Maidul, Nain, Zulkar, Roy, Rajib Kanti, Haque, Anwarul, Barman, Shital Kumar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2020
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606404/
https://ncbi.nlm.nih.gov/pubmed/33089409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-020-00218-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia